These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 3002662
21. Effect of milrinone on myocardial mechanical function and cyclic AMP content in the fetal rabbit. Ogawa S, Nakanishi T, Kamata K, Takao A. Pediatr Res; 1987 Sep; 22(3):282-5. PubMed ID: 2443896 [Abstract] [Full Text] [Related]
22. Enhanced relaxation and reduced positive inotropic effects of amrinone in ventricular muscle from cats with subacute heart failure. Implications for drug therapy. Bassett AL, Gaide MS, Lodge NJ, Cameron JS. Adv Myocardiol; 1985 Sep; 6():629-36. PubMed ID: 2986264 [Abstract] [Full Text] [Related]
27. In-vivo effects of amrinone and milrinone on left ventricular dP/dt, intraventricular pressure and heart rate in pentobarbital-anesthetized guinea pigs. Lin BB, Chen HL. Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):237-40. PubMed ID: 1811284 [Abstract] [Full Text] [Related]
29. Effects of amrinone on myocardial energetics in severe congestive heart failure. Baim DS. Am J Cardiol; 1985 Jul 22; 56(3):16B-18B. PubMed ID: 3161318 [Abstract] [Full Text] [Related]
30. Bipyridine cardiotonics: the three-dimensional structures of amrinone and milrinone. Robertson DW, Beedle EE, Swartzendruber JK, Jones ND, Elzey TK, Kauffman RF, Wilson H, Hayes JS. J Med Chem; 1986 May 22; 29(5):635-40. PubMed ID: 3701782 [Abstract] [Full Text] [Related]
32. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP? Kitada Y, Narimatsu A, Suzuki R, Endoh M, Taira N. J Pharmacol Exp Ther; 1987 Nov 22; 243(2):639-45. PubMed ID: 2824754 [Abstract] [Full Text] [Related]
34. Increase in Ca++ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig papillary muscles. Kitada Y, Narimatsu A, Matsumura N, Endo M. J Pharmacol Exp Ther; 1987 Nov 22; 243(2):633-8. PubMed ID: 3500301 [Abstract] [Full Text] [Related]
36. Myocardial actions of milrinone: characterization of its mechanism of action. Rapundalo ST, Grupp I, Grupp G, Abdul Matlib M, Solaro RJ, Schwartz A. Circulation; 1986 Mar 22; 73(3 Pt 2):III134-44. PubMed ID: 2417746 [Abstract] [Full Text] [Related]
37. The effect of phosphodiesterase III inhibitors on human neutrophil function. Mikawa K, Akamatsu H, Nishina K, Shiga M, Maekawa N, Obara H, Niwa Y. Crit Care Med; 2000 Apr 22; 28(4):1001-5. PubMed ID: 10809273 [Abstract] [Full Text] [Related]
38. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog. Lebedinsky Y, Nordstrom ST, Aschoff SE, Kapples JF, O'Malley GJ, Kosley RW, Fielding S, Hubbard JW. J Cardiovasc Pharmacol; 1992 May 22; 19(5):779-89. PubMed ID: 1381777 [Abstract] [Full Text] [Related]
39. Effects of epinephrine and phosphodiesterase III inhibitors on bupivacaine-induced myocardial depression in guinea-pig papillary muscle. Azuma M, Yamane M, Tachibana K, Morimoto Y, Kemmotsu O. Br J Anaesth; 2003 Jan 22; 90(1):66-71. PubMed ID: 12488382 [Abstract] [Full Text] [Related]
40. Electrophysiologic and proarrhythmic effects of intravenous inotropic agents. Tisdale JE, Patel R, Webb CR, Borzak S, Zarowitz BJ. Prog Cardiovasc Dis; 1995 Jan 22; 38(2):167-80. PubMed ID: 7568905 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]